Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: 3bar who wrote (4977)	9/20/2017 10:27:39 AM
From: Kirk ©	Read Replies (2) \| Respond to of 26459

Thanks. TLT.v has some great sounding technology that reminds me in many ways of NNVC - NanoViricides, Inc. That is technology with great promise not recognized by investors. Perhaps the companies have similar flaws where by owning the stock you really don't own the technology, just get to help pay those who do a fee to develop it with participation possible in some of the profits if they don't go under first and come back clean as a new company with the tech they own. The technologies seem so great I wonder why someone like Pfizer doesn't just buy 25% of the stock or more much as Incyte has done for another of my high risk stocks, Antigenics (AGEN) . Perhaps this will come after they get some human trial data?